Drugmakers cannot replace upfront discounts with their own rebate models without federal approval, although the ruling leaves HHS free to authorize a future system.

The industry group says its reform effort remains on track despite questions about participation, oversight and continuity-of-care protections.

The Michigan health system alleges CVS manipulated specialty-drug reimbursements and retaliated against hospitals seeking an audit of the arrangement.

The court found that The Guardian's reporting about undisclosed bonuses and Medicare Advantage patient care was substantially true or otherwise protected.

The AtaiBeckley acquisition follows new federal efforts to accelerate research, regulatory review and clinical preparations for psychedelic therapies.

Seven in 10 health care professionals said the system is less stable today than it was two years ago.

J.P. Morgan survey finds many workers don't know whether they're saving enough for retirement, fueling demand for clearer employer guidance, simpler plan design and financial wellness support.

A federal judge has dismissed with prejudice a lawsuit accusing medical billing company HaloMD and two physician groups of defrauding Blue Cross Blue Shield of Georgia through the No Surprises Act's independent dispute resolution process, marking the latest court to reject insurers' efforts to challenge arbitration outcomes through separate litigation.